Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Factor XIII and endothelial barrier function].

Th Noll1, G Wozniak

  • 1Physiologisches Institut, Justus-Liebig-Universität Giessen. Thomas.Noll@physiologie.med.uni-giessen.de

Hamostaseologie
|August 24, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Non-invasive methods for diagnosing pregnancy in cows and their real value.

Polish journal of veterinary sciences·2024
Same author

Ultrahypofractionated CyberKnifeTM based stereotactic radiotherapy versus conventional radiotherapy in patients with prostate cancer - acute toxicity evaluation in two phase II prospective studies.

Neoplasma·2017
Same author

Acute toxicity of robotic ultrahypofractionated radiotherapy CyberKnifeTM in prostate cancer patients.

Neoplasma·2015
Same author

Daily image-guidance in prostate cancer radiotherapy - implications for treatment margins.

Neoplasma·2015
Same author

Split-course accelerated hyperfractionated irradiation (CHA-CHA) as a sole treatment for advanced head and neck cancer patients-final results of a randomized clinical trial.

The British journal of radiology·2014
Same author

Optimization of circulating cell-free DNA recovery for KRAS mutation and HPV detection in plasma.

Cancer biomarkers : section A of Disease markers·2014

Activated factor XIII (FXIIIa) stabilizes the endothelial barrier by reducing permeability and preventing barrier failure. This protein cross-links extracellular matrix proteins, enhancing tissue repair and wound healing.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Physiology

Context:

  • Activated factor XIII (FXIIIa) is crucial for hemostasis and fibrinolysis.
  • FXIIIa also influences cell adhesion, migration, extracellular matrix generation, and tissue repair.
  • Recent research highlights FXIIIa's role in maintaining endothelial barrier integrity.

Purpose:

  • To investigate the role of FXIIIa in endothelial barrier function.
  • To elucidate the mechanisms by which FXIIIa stabilizes endothelial cells.
  • To explore FXIIIa's potential in preventing vascular barrier dysfunction.

Summary:

  • FXIIIa stabilizes endothelial barrier function by reducing macromolecule permeability in endothelial monolayers.
  • It prevents endothelial barrier failure in coronary arteries.

Related Experiment Videos

  • This stabilization is achieved through cross-linking of extracellular matrix proteins in interendothelial clefts.

    • Impact:

    • FXIIIa's endothelial stabilizing properties offer new therapeutic targets for vascular diseases.
    • Understanding FXIIIa's role can advance treatments for conditions involving increased vascular permeability.
    • This research deepens the understanding of hemostasis and tissue repair mechanisms.